<h4>Background</h4>High-sensitivity C-reactive protein (hs-CRP) and stress hyperglycemia ratio (SHR) are recognized as predictors of major adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction (STEMI). This evidence concerns the gene CRP and Hyperglycemia.